EPO and atherosclerosis: Further studies are necessary to investigate whether other immune cells involved in the inflammatory response and in atherosclerosis may be more sensitive to this recommended dose of EPO and whether higher doses of EPO as used in cardiovascular trials do affect monocyte gene expression.